MetLife Investment Management’s Arcosa ACA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.19M | Buy |
28,833
+2,292
| +9% | +$285K | 0.02% | 749 |
|
|
2026
Q1 | $2.82M | Sell |
26,541
-534
| -2% | -$60.7K | 0.01% | 882 |
|
|
2025
Q4 | $2.88M | Sell |
27,075
-1,300
| -5% | -$131K | 0.01% | 889 |
|
|
2025
Q3 | $2.66M | Buy |
+28,375
| New | +$2.64M | 0.01% | 950 |
|
|
2025
Q2 | – | Sell |
-28,275
| Closed | -$2.18M | – | 2731 |
|
|
2025
Q1 | $2.18M | Sell |
28,275
-1,017
| -3% | -$93.3K | 0.01% | 998 |
|
|
2024
Q4 | $2.83M | Buy |
29,292
+1,293
| +5% | +$130K | 0.02% | 872 |
|
|
2024
Q3 | $2.65M | Hold |
27,999
| – | – | 0.02% | 873 |
|
|
2024
Q2 | $2.34M | Buy |
27,999
+3,073
| +12% | +$256K | 0.01% | 899 |
|
|
2024
Q1 | $2.14M | Sell |
24,926
-505
| -2% | -$41.1K | 0.01% | 925 |
|
|
2023
Q4 | $2.1M | Hold |
25,431
| – | – | 0.02% | 927 |
|
|
2023
Q3 | $1.83M | Sell |
25,431
-524
| -2% | -$39.8K | 0.01% | 937 |
|
|
2023
Q2 | $1.97M | Buy |
25,955
+186
| +0.7% | +$12.5K | 0.01% | 936 |
|
|
2023
Q1 | $1.63M | Hold |
25,769
| – | – | 0.01% | 986 |
|
|
2022
Q4 | $1.4M | Hold |
25,769
| – | – | 0.01% | 1044 |
|
|
2022
Q3 | $1.47M | Buy |
25,769
+519
| +2% | +$28.8K | 0.01% | 1008 |
|
|
2022
Q2 | $1.17M | Sell |
25,250
-731
| -3% | -$38.3K | 0.01% | 1130 |
|
|
2022
Q1 | $1.49M | Buy |
25,981
+9,338
| +56% | +$481K | 0.01% | 1119 |
|
|
2021
Q4 | $877K | Sell |
16,643
-1,741
| -9% | -$93.1K | 0.01% | 1187 |
|
|
2021
Q3 | $922K | Hold |
18,384
| – | – | 0.01% | 1156 |
|
|
2021
Q2 | $1.08M | Hold |
18,384
| – | – | 0.01% | 1120 |
|
|
2021
Q1 | $1.2M | Sell |
18,384
-2,110
| -10% | -$130K | 0.01% | 1072 |
|
|
2020
Q4 | $1.13M | Buy |
20,494
+1,098
| +6% | +$56K | 0.01% | 1076 |
|
|
2020
Q3 | $855K | Sell |
19,396
-1,926
| -9% | -$84.7K | 0.01% | 1105 |
|
|
2020
Q2 | $900K | Hold |
21,322
| – | – | 0.01% | 1077 |
|
|
2020
Q1 | $847K | Buy |
21,322
+1,354
| +7% | +$57.2K | 0.01% | 974 |
|
|
2019
Q4 | $890K | Sell |
19,968
-2,139
| -10% | -$82.3K | 0.01% | 1151 |
|
|
2019
Q3 | $756K | Hold |
22,107
| – | – | 0.01% | 1195 |
|
|
2019
Q2 | $832K | Buy |
22,107
+22,041
| +33,395% | +$754K | 0.01% | 1197 |
|
|
2019
Q1 | $2.02K | Hold |
66
| – | – | ﹤0.01% | 2540 |
|
|
2018
Q4 | $1.83K | Buy |
+66
| New | +$1.81K | ﹤0.01% | 2543 |
|
Other funds holding ACA
NAMI
RA
MetLife Investment Management's ACA Position: Q2 2026 in Review
MetLife Investment Management increased its Arcosa (ACA) stake by 8.6% in Q2 2026, buying an estimated $285K and bringing the position to 28,833 shares worth $4.19M. The position accounts for 0.02% of the portfolio, ranked #749.
MetLife Investment Management first reported a position in ACA in Q4 2018 and has held it in 30 quarters since. 425 funds tracked by Wall St. Rank hold ACA as of Q2 2026.
- MetLife Investment Management held 28,833 shares of Arcosa worth $4.19M as of Q2 2026.
- MetLife Investment Management bought 2,292 Arcosa shares in Q2 2026, an estimated $285K.
- Arcosa made up 0.02% of MetLife Investment Management's portfolio in Q2 2026, its #749 holding.
- MetLife Investment Management first reported a position in Arcosa in Q4 2018 and has held it in 30 quarters since.
- 425 funds tracked by Wall St. Rank held Arcosa as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.